Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
Public ClinicalTrials.gov record NCT01529034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Study identification
- NCT ID
- NCT01529034
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB Biopharma S.P.R.L.
- Industry
- Enrollment
- 175 participants
Conditions and interventions
Conditions
Interventions
- USL261 Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012
- Primary completion
- Mar 31, 2017
- Completion
- Not listed
- Last update posted
- Jan 19, 2023
Started 2012
United States locations
- U.S. sites
- 31
- U.S. states
- 21
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| United States, Arizona | Phoenix | Arizona | — | — |
| United States, Arizona | Scottsdale | Arizona | — | — |
| United States, Arizona | Tucson | Arizona | — | — |
| United States, Arkansas | Little Rock | Arkansas | — | — |
| United States, California | Fresno | California | — | — |
| United States, California | Sacramento | California | — | — |
| United States, California | Ventura | California | — | — |
| United States, Colorado | Aurora | Colorado | — | — |
| United States, Connecticut | New Haven | Connecticut | — | — |
| United States, Florida | Port Charlotte | Florida | — | — |
| United States, Florida | Wellington | Florida | — | — |
| United States, Idaho | Boise | Idaho | — | — |
| United States, Illinois | Chicago | Illinois | — | — |
| United States, Kentucky | Lexington | Kentucky | — | — |
| United States, Maryland | Baltimore | Maryland | — | — |
| United States, Michigan | Detroit | Michigan | — | — |
| United States, Minnesota | Saint Paul | Minnesota | — | — |
| United States, Missouri | St Louis | Missouri | — | — |
| United States, New Hampshire | Lebanon | New Hampshire | — | — |
| United States, New Jersey | Hackensack | New Jersey | — | — |
| United States, New York | New York | New York | — | — |
| United States, New York | Stony Brook | New York | — | — |
| United States, New York | The Bronx | New York | — | — |
| United States, North Carolina | Durham | North Carolina | — | — |
| United States, North Carolina | Winston-Salem | North Carolina | — | — |
| United States, Oklahoma | Oklahoma City | Oklahoma | — | — |
| United States, Pennsylvania | Philadelphia | Pennsylvania | — | — |
| United States, Tennessee | Memphis | Tennessee | — | — |
| United States, Tennessee | Nashville | Tennessee | — | — |
| United States, Texas | Dallas | Texas | — | — |
| United States, Texas | Greenville | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01529034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01529034 live on ClinicalTrials.gov.